Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.96.

  • Organogenesis Holdings' Asset Utilization Ratio fell 634.4% to 0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96, marking a year-over-year decrease of 634.4%. This contributed to the annual value of 1.01 for FY2024, which is 565.25% up from last year.
  • Per Organogenesis Holdings' latest filing, its Asset Utilization Ratio stood at 0.96 for Q3 2025, which was down 634.4% from 0.93 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Asset Utilization Ratio registered a high of 1.28 during Q2 2021, and its lowest value of 0.93 during Q2 2025.
  • For the 5-year period, Organogenesis Holdings' Asset Utilization Ratio averaged around 1.04, with its median value being 1.02 (2023).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 6333.63% in 2021, then surged by 875.5% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Asset Utilization Ratio (Quarter) stood at 1.15 in 2021, then fell by 13.41% to 0.99 in 2022, then decreased by 5.61% to 0.94 in 2023, then grew by 8.75% to 1.02 in 2024, then dropped by 6.15% to 0.96 in 2025.
  • Its Asset Utilization Ratio stands at 0.96 for Q3 2025, versus 0.93 for Q2 2025 and 0.95 for Q1 2025.